Cargando…

A public health approach to cervical cancer screening in Africa through community‐based self‐administered HPV testing and mobile treatment provision

The World Health Organization (WHO) refers to cervical cancer as a public health problem, and sub‐Saharan Africa bears the world's highest incidence. In the realm of screening, simplified WHO recommendations for low‐resource countries now present an opportunity for a public health approach to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakalembe, Miriam, Makanga, Philippa, Kambugu, Andrew, Laker‐Oketta, Miriam, Huchko, Megan J., Martin, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666725/ https://www.ncbi.nlm.nih.gov/pubmed/32966684 http://dx.doi.org/10.1002/cam4.3468

Ejemplares similares

A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma
por: Semeere, Aggrey, et al.
Publicado: (2016)

Using Media to Promote Public Awareness of Early Detection of Kaposi's Sarcoma in Africa
por: Laker-Oketta, Miriam, et al.
Publicado: (2020)

Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda
por: Nakalembe, Miriam, et al.
Publicado: (2019)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

A systematic review of the HPV‐attributable fraction of oropharyngeal squamous cell carcinomas in Germany
por: Reuschenbach, Miriam, et al.
Publicado: (2019)

The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications
por: Hu, Zheng, et al.
Publicado: (2018)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
por: Abulizi, Guzhalinuer, et al.
Publicado: (2021)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

HPV‐vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
por: Altobelli, Emma, et al.
Publicado: (2019)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019)

A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women
por: Wu, Qiongyan, et al.
Publicado: (2017)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
por: Depuydt, Christophe E, et al.
Publicado: (2015)

Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial
por: Sewali, Barrett, et al.
Publicado: (2015)

Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV‐positive women attending public health centers in Addis Ababa city, Ethiopia
por: Shiferaw, Saba, et al.
Publicado: (2018)

The potential population‐based impact of an HPV vaccination intervention in Colorado
por: Cataldi, Jessica R., et al.
Publicado: (2019)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

Surgical candidacy and treatment initiation among women with cervical cancer at public referral hospitals in Kampala, Uganda: a descriptive cohort study
por: Swanson, Megan, et al.
Publicado: (2020)

Current trends in the etiology and diagnosis of HPV-related head and neck cancers
por: Chai, Ryan C, et al.
Publicado: (2015)

Missed opportunities for concomitant HPV vaccination among childhood cancer survivors
por: Ramsay, Joemy M., et al.
Publicado: (2022)

The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries
por: Huchko, Megan J, et al.
Publicado: (2015)

The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia
por: Zhang, Chaoting, et al.
Publicado: (2018)

Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies
por: Auguste, Aviane, et al.
Publicado: (2020)

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
por: Gultekin, Murat, et al.
Publicado: (2017)

Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme
por: Macios, Anna, et al.
Publicado: (2021)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
por: Schwarz, Tino F., et al.
Publicado: (2017)

Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns
por: Fokom Domgue, Joël, et al.
Publicado: (2020)

Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older—A national cohort study
por: Hammer, Anne, et al.
Publicado: (2019)

A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western Kenya
por: Isaacson, Sinéad, et al.
Publicado: (2022)

Determinants of mobile technology use and smartphone application interest in cancer patients
por: Raghunathan, Nirupa Jaya, et al.
Publicado: (2018)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
por: Clarke, Megan A., et al.
Publicado: (2021)

A rigorous exploration of anal HPV genotypes using a next‐generation sequencing (NGS) approach in HIV‐infected men who have sex with men at risk for developing anal cancer
por: Piyathilake, Chandrika J., et al.
Publicado: (2019)

Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
por: Schonfeld, Sara J., et al.
Publicado: (2016)

Implementing the 3T‐approach for cervical cancer screening in Cameroon: Preliminary results on program performance
por: Levy, Juliette, et al.
Publicado: (2020)

Performance of cervical cancer screening and triage strategies among women living with HIV in China
por: Duan, Rufei, et al.
Publicado: (2021)

A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Benard, Vicki B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eo5qkkf9lok01u56gqjgrv2g62